References

Aharoni, A., L. Gaidukov, S. Yagur, L. Toker, I. Silman and D.S. Tawfik, 2004. Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. Proc. Natl. Acad. Sci. USA., 101: 482-487.
CrossRef  |  

Akcapinar, H., 2000. Sheep Breeding. Ismat Printing Company, Ankara, Pages: 187.

Akgur, S.A., P. Ozturk, I. Solak, A.R. Moralb and B. Ege, 2003. Human serum paraoxonase (PON1) activity in acute organophosphorus insecticide poisoning. Forensic Sci. Int., 133: 136-140.
CrossRef  |  

Aldridge, W.N., 1953. Differentiation of true and pseudo cholinesterase by organophosphorus compounds. Biochem. J., 53: 62-67.
Direct Link  |  

Billecke, S., D. Draganov, R. Counsell, P. Stetson, C. Watson, C. Hsu and B.N. La Du, 2000. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab. Dispos., 28: 1335-1342.
Direct Link  |  

Chambers, H.W., J.S. Boone, R.L. Carr and J.E. Chambers, 2001. Chemistry of Organophosphorus Insecticides. In: Handbook of Pesticide Toxicology, Krieger, R.I. (Ed.). Vol. 2. Academic Press, San Diego, pp: 913-917.

Cocker, J., H.J. Mason, S.J. Garfitt and K. Jones, 2002. Biological monitoring of exposure to organophosphate pesticides. Toxicol. Lett., 134: 97-103.
CrossRef  |  

Costa, L.G., 2006. Current issues in organophosphate toxicology. Clin. Chim. Acta, 366: 1-13.
CrossRef  |  Direct Link  |  

Costa, L.G., T.B. Cole, A. Vitalone and C.E. Furlong, 2005. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clinica Chimica Acta, 352: 37-47.
CrossRef  |  

Deakin, S. and R. James, 2004. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin. Sci., 107: 435-447.
PubMed  |  

Draganov, D.I. and B.N. La Du, 2004. Pharmacogenetics of paraoxonases: A brief review. Naunyn-Schmiedebergs Arch. Pharmacol., 369: 78-88.
PubMed  |  

Durrington, P.N., B. Mackness and M.I. Mackness, 2001. Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 21: 473-480.
PubMed  |  Direct Link  |  

Ekinci, D. and S. Beydemir, 2009. Evaluation of the impacts of antibiotic drugs on PON 1: A major bioscavenger against cardiovascular diseases. Eur. J. Pharmacol., 617: 84-89.
Direct Link  |  

Evison, D., D. Hinsley and P. Rice, 2002. Chemical weapons. Br. Med. J., 324: 235-332.

Eyer, P., L. Szinicz, H. Thiermann, F. Worek and T. Zilker, 2007. Testing of antidotes for organophosphorus compounds: Experimental procedures and clinical reality. Toxicology, 233: 108-119.
CrossRef  |  

Gaidukov, L. and D.S. Tawfik, 2005. High affinity, stability and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I. Biochemistry, 44: 11843-11854.
PubMed  |  

Gan, K.N., A. Smolen, H.W. Eckerson and B.N. La Du, 1991. Purification of human serum paraoxonase/arylesterase, evidence for one esterase catalyzing both activities. Drug Metab. Dispos., 19: 100-106.
PubMed  |  

Goswami, B., D. Tayal, N. Gupta and V. Mallika, 2009. Paraoxonase: A multifaceted biomolecule. Clinica Chimica Acta, 410: 1-12.
CrossRef  |  

Hernandez, A.F., M.A. Gomez, V. Perez, J.V. Garcia-Lario and G. Pena et al., 2006. Influence of exposure to pesticides on serum components and enzyme activities of cytotoxicity among intensive agriculture farmers. Environ. Res., 102: 70-76.
CrossRef  |  Direct Link  |  

Jansen, K.L., T.B. Cole, S.S. Park, C.E. Furlong and L.G. Costa, 2009. Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds. Toxicol. Applied Pharmacol., 236: 142-153.
CrossRef  |  

Jaouad, L., C. de Guise, H. Berrougui, M. Cloutiera and M. Isabellea et al., 2006. Age-related decrease in highdensity lipoproteins antioxidant activity is due to an alteration in the PON1s free sulfhydyl groups. Atherosclerosis, 185: 191-200.
CrossRef  |  

Kaymakci, M., 2006. Advanced Sheep Breeding. Sheep and Goat Breeders Association, Izmir, Turkey, pp: 49-77.

Khersonsky, O. and D.S. Tawfik, 2006. The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases. J. Biol. Chem., 281: 7649-7656.
PubMed  |  

Koyuncu, M. and S.K. Uzun, 2009. Growth performance of Karacabey Merino and Kivircik lambs under semi-intensive management in Turkey. Small Ruminant Res., 83: 64-66.
CrossRef  |  

La Du, B.N., 1992. Human Serum Paraoxonase/Arylesterase. In: Pharmacogenetics of Drug Metabolism, Kalow, W. (Ed.). Pergamon Press, New York, pp: 51-91.

Li, W.F., L.G. Costa and C.E. Furlong, 1993. Serum paraoxonase status-a major factor in determining resistance to organophosphates. J. Toxicol. Environ. Health, 40: 337-346.
CrossRef  |  

Li, W.F., L.G. Costa, R.J. Richter, T. Hagen and D.M. Shih et al., 2000. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics, 10: 767-779.
PubMed  |  

Lopez, O., A.F. Hernandez, L. Rodrigo, F. Gil and G. Pena et al., 2007. Changes in antioxidant enzymes in humans with long-term exposure to pesticides. Toxicol. Lett., 171: 146-153.
CrossRef  |  Direct Link  |  

Maroni, M., C. Colosio, A. Ferioli and A. Fait, 2000. Biological monitoring of pesticide exposure: A review. Introduction. Toxicology, 143: 1-118.
PubMed  |  Direct Link  |  

Nguyen, S.D., N.D. Hung, P. Cheon-Ho, K.M. Ree and S. Dai-Eun, 2009. Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1). Biochimica Biophysica Acta, 1790: 155-160.
CrossRef  |  

Povey, A.C., 2010. Gene-environmental interactions and organophosphate toxicity. Toxicology, 10.1016/j.tox.2010.02.007

Rahimi, R. and M. Abdollahi, 2007. A review on the mechanisms involved in hyperglycemia induced by organophosphorus pesticides. Pestic. Biochem. Physiol., 88: 115-121.
CrossRef  |  Direct Link  |  

Sahin, E.H., M. Yardimci, I.S. Cetingul, I. Bayram and E. Sengor, 2008. The use of ultrasound to predict the carcass composition of live Akkaraman lambs. Meat Sci., 79: 716-721.
CrossRef  |  

Shih, D.M., L. Gu, Y.R. Xia, M. Navab and W.F. Li et al., 1998. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature, 394: 284-287.
PubMed  |  

Teiber, J.F., D.I. Draganov and B.N. la Du, 2003. Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3. Biochem. Pharmacol., 66: 887-896.
CrossRef  |  

Trainor, M., H. Mason, J. Cocker, H. Chambers, R. Guiver and S. Wright, 2002. Risk assessment for acute toxicity from sheep ectoparasite treatments, including organophosphates (OPs) used in plunge dipping. Health and Safety Laboratory HSL/2002/26, Sheffield, UK. http://www.hse.gov.uk/research/hsl_pdf/2002/hsl02-26.pdf.

Turk, R., D. Juretic, D. Geres, N. Turk, B. Rekic, V. Simeon-Rudolf and A. Svetina, 2004. Serum paraoxonase activity and lipid parameters in the early postpartum period of dairy cows. Res. Vet. Sci., 76: 57-61.
CrossRef  |  

Wesseling, C., R. McConnell, T. Partanen and C. Hogstedt, 1997. Agricultural pesticide use in developing countries: Health effects and research needs. Int. J. Health Serv., 27: 273-308.
PubMed  |  

Yalcin, B.C., 1986. Sheep and goats in Turkey. Food and Agriculture Organization of the United Nations, Animal Production and Health, Paper No. 60, Rome. http://www.fao.org/docrep/009/ah224e/ah224e00.htm.